Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...

Investing.com-- Bank of America (BofA) analysts highlighted several Japanese stocks as top picks following strong ...

We recently compiled a list of the 12 Best Japanese Stocks To Buy in 2025. In this article, we are going to take a look at ...

Elite Pharmaceuticals experienced a mixed performance in Q3 2024. While quarterly revenues decreased to $14.4 million, the company reported a significant 35% increase in nine-month revenues ...

Q3 Results, Earnings Today: Today, majors like Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Alembic Pharma, Castrol India, Taj GVK Hotels & Resorts, and others are releasing their ...

SBI Q3 Results LIVE: Capital Adequacy Ratio (CAR) as at the end of Q3FY25 stands at 13.03%, shows an exchange filing. - Credit growth at 13.49% YoY with domestic advances growing by 14.06% YoY.

However, the company’s total premium surged 37 per cent to ₹1,151 crore in Q3FY25 of this fiscal against ₹841 crore in Q3 of FY24, driven by group premium which more than doubled year-on ...

Follow our LIVE blog for the latest updates. We wrap up today's edition of the Moneycontrol live Q3 earnings blog, and will be back tomorrow morning with all the latest updates and alerts.

Arm Holdings will hold its Q3 2025 earnings call today at 2 p.m. PT/5 p.m. ET. We’ll be streaming it on the Shacknews Twitch channel. You can also find it on Arm’s investor relations website.

ARM stock is in a strong bullish trend, trading above key moving averages ahead of Q3 earnings. Analysts maintain a bullish rating but see a 7% downside from current levels based on price targets.

Follow our LIVE blog for the latest updates. We wrap up today's edition of the Moneycontrol live Q3 earnings blog, and will be back tomorrow morning with all the latest updates and alerts.